Phacilitate Cell and Gene Therapy Forum 2005. Cell and gene therapy: a corporate perspective. 24-26 January 2005, Washington, DC, USA.
Salmons
Brian
B
Austrianova Biotechnology GmbH, Veterinaerplatz 1, A-1210 Vienna, Austria. salmons@austrianova.com
D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D001549:Benzamides; D002166:Camptothecin / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use; D064987:Cell- and Tissue-Based Therapy / Q000191:economics / Q000379:methods* / Q000639:trends; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004164:Diphosphonates / Q000737:chemistry / Q000627:therapeutic use; D016520:Entrepreneurship / Q000191:economics / Q000639:trends; D015316:Genetic Therapy / Q000191:economics / Q000379:methods* / Q000639:trends; D006801:Humans; D000068877:Imatinib Mesylate; D007093:Imidazoles / Q000737:chemistry / Q000627:therapeutic use; D015394:Molecular Structure; D010793:Phthalazines / Q000737:chemistry / Q000627:therapeutic use; D010879:Piperazines / Q000737:chemistry / Q000627:therapeutic use; D011725:Pyridines / Q000737:chemistry / Q000627:therapeutic use; D011743:Pyrimidines / Q000737:chemistry / Q000627:therapeutic use; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D001549:Benzamides; D004164:Diphosphonates; D007093:Imidazoles; D010793:Phthalazines; D010879:Piperazines; D011725:Pyridines; D011743:Pyrimidines; C433984:ST 1481; C404768:vatalanib; D000077211:Zoledronic Acid; D000068877:Imatinib Mesylate; D002166:Camptothecin